tiprankstipranks
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
US Market
IOVA
Iovance Biotherapeutics
RESEARCH TOOLSreports
Want to see IOVA full AI Analyst Report?

Iovance Biotherapeutics (IOVA) Income Statement

4,088 Followers

Iovance Biotherapeutics Income Statement

Last quarter (Q4 2025), Iovance Biotherapeutics's total revenue was $86.77M, an increase of 17.74% from the same quarter last year. In Q4, Iovance Biotherapeutics's net income was $-71.90M. See Iovance Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 263.50M$ 164.07M$ 1.19M$ 0.00$ 0.00
Gross Profit
$ 256.22M$ 40.08M$ -9.57M$ 0.00$ 0.00
Operating Expenses
$ 659.57M$ 435.35M$ 450.99M$ 398.88M$ 342.70M
Depreciation and Amortization
$ 35.94M$ 43.61M$ 33.13M$ 21.14M$ 13.98M
EBITDA
$ -357.11M$ -351.67M$ -427.43M$ -377.74M$ -328.72M
Operating Income
$ -403.36M$ -395.28M$ -460.56M$ -398.88M$ -342.70M
Other Income/Expenses
$ 10.31M$ 20.27M$ 13.04M$ 2.98M$ 451.00K
Pretax Income
$ -393.05M$ -375.00M$ -447.52M$ -395.89M$ -342.25M
Net Income
$ -390.98M$ -372.18M$ -444.04M$ -395.89M$ -342.25M
Per Share Metrics
Basic EPS
$ -1.09$ -1.28$ -1.89$ -2.49$ -2.23
Diluted EPS
$ -1.09$ -1.28$ -1.89$ -2.49$ -2.23
Weighted Average Shares Outstanding
 357.35M 289.88M 235.13M 159.26M 153.41M
Weighted Average Shares Outstanding (Diluted)
 357.35M 289.88M 235.13M 159.26M 153.41M
Currency in USD

Iovance Biotherapeutics Earnings and Revenue History